The Australasian Society for Ultrasound in Medicine (ASUM) has today welcomed the commitment of indexation following the Health Budget announcements. Access and affordability have long been a concern for our patients, with ultrasound examinations routinely used for initial disease diagnosis, as well as ongoing management.
The Australian public pays significant out-of-pocket healthcare costs for ultrasound services. Indexation for ultrasound and all imaging services have been frozen for more than 20 years. The government have committed to invest $198.6 million to increase the Medicare rebate for ultrasound and x-ray services. This will likely equate to a 1.5 to 2% increase to each Medicare item for ultrasound.
ASUM President A/Prof Fred Joshua said the funding announcements were timely.
”Patients should not miss vital examinations to assist with a diagnosis or management of a health condition due to out of pocket costs and reduced access to care,” A/Prof Joshua said.
Women’s health has also benefited. Ultrasound is often the first line of examination for pregnancy and gynaecological investigation and a number of improvements have been introduced in the budget for women undergoing treatment for breast cancer.
A patient diagnosed with breast cancer will often require multiple ultrasound examinations in addition to the initial diagnosis. Financial burden is often an added complication to an already overwhelming diagnosis. The following is a typical routine for many of our patients and therefore indexation implementation will help with access and patient care;
-
Breast ultrasound and mammography for diagnosis of a cancer
-
Breast ultrasound for the purpose of a biopsy (FNA or core)
-
Clip placement pre-chemotherapy under ultrasound guidance
-
Breast ultrasound during chemotherapy to assess reduction in tumour size
-
Breast ultrasound pre-surgical to assist with planning (often in conjunction with other imaging) PET and/or breast MRI where indicated
-
Post-surgical breast ultrasound
-
Ongoing surveillance/follow up in conjunction with mammography
The Budget highlighted the commitment to guaranteeing Medicare and improving access to medicines; supporting our hospitals; prioritising mental health, preventive health and sport; investing in health and medical research and continuing to progress aged care reform, focusing on improving access and quality of care. These priorities are outlined in the Portfolio Budget Statement.
The Government has announced significant increased investment across many areas of the portfolio, including:
-
$6 billion in Medicare
-
$1.1 billion in primary care
-
$40 billion provision for medicines
-
$1.25 billion for the Community Health and Hospitals Program
-
$7 billion for aged care
In addition, significant investments have been made in mental health, key hospital services, prevention and management of chronic disease and other lifestyle-related diseases, and research through the new 10-year investment plan for the Medical Research Future Fund.
The Budget sees an increase of $20 billion over the forward estimates for the Health portfolio, from $102 billion in 2018–19 to $115 billion in 2022–23.
|